US nears deal to fund Moderna’s bird flu vaccine trial, FT reports
The U.S. government is nearing an agreement to fund a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine, the Financial Times reported on Thursday, as an H5N1 outbreak spreads through egg farms and among cattle herds.